REGN: Regeneron Pharmaceuticals Inc

REGN haberleri

• Zacks 21:25 Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
• Zacks 13:15 Unlocking Q2 Potential of Regeneron (REGN): Exploring Wall Street Estimates for Key Metrics
• Investing 19:43 Biotech stocks dip as Trump administration mulls patent fee overhaul
• Zacks 14:00 Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
• The Motley Fool 13:15 2 Healthcare Stocks That Are Losing to the S&P 500 This Year
• Zacks 14:00 Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
• Zacks 13:58 REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
• Seeking Alpha 00:40 Fidelity OTC Portfolio Q2 2025 Commentary (undefined:FOCPX)
• Seeking Alpha 16:00 Fidelity Contrafund Q2 2025 Commentary (undefined:FCNTX)
• Zacks 14:46 Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
• TipRanks 10:46 QQQ ETF News, 7/24/2025 - TipRanks.com
• Seeking Alpha 11:00 Longleaf Partners Global Fund Q2 2025 Commentary (LLGLX)
• Benzinga 18:15 Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
• Seeking Alpha 13:25 Longleaf Partners Fund Q2 2025 Commentary (LLPFX)
• TipRanks 10:35 QQQ ETF News, 7/22/2025 - TipRanks.com
• The Motley Fool 10:09 After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
• Zacks 13:52 Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?
• Investing 11:40 H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
• TipRanks 11:00 QQQ ETF News, 7/18/2025 - TipRanks.com
• Zacks 12:22 BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
• Seeking Alpha 03:40 Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff (AMGN)
• Investor's Business Daily 12:09 Stock Market Today: Dow Falls As American Express Tumbles; Advanced Micro Leads Nasdaq Higher (Live Coverage)
• Seeking Alpha 14:46 AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
• Investor's Business Daily 15:41 Stock Market Holds At Record Highs Despite Trump Tariffs: Weekly Review